Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMissing a Mounjaro shot does not mean starting from scratch. According to the Mounjaro prescribing guidance, if you miss a dose and your next scheduled injection is still more than four days away, you can take the missed dose as soon as you remember. If fewer than four days remain before your next dose is due, skip the missed one and continue on your usual day. The medicine stays in your system — tirzepatide has a half-life of roughly five days — so a single missed shot is unlikely to undo your progress. That said, these medicines are prescription-only, and your prescriber is always the right person to guide any changes to your schedule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro Patient Information Leaflet, which sits on the Electronic Medicines Compendium (eMC), sets out the missed-dose decision clearly. The cut-off is four days before your next scheduled injection. More than four days remaining? Take the missed dose straight away, then return to your usual weekly day. Four days or fewer left? Leave the missed dose entirely and inject on your normal day as planned.
This rule exists because tirzepatide is a once-weekly medicine with a long half-life. A few extra days without a dose is measurably different from missing an entire week. The guidance reflects that distinction rather than applying one blanket instruction.
One practical note: people often miss doses around busy patches, a bank holiday, a holiday abroad, a week where the pen was left at home. Knowing the four-day window in advance means you can make the call without unnecessary worry. The question of missing a full week is slightly different and worth reading separately if that applies to you.
Tirzepatide works partly by slowing gastric emptying and acting on appetite-regulating hormones, so when levels dip, hunger can edge back. Most people notice this within a few days of a missed dose rather than immediately, the drug clears gradually, not overnight.
Some people also find that gastrointestinal side effects, such as nausea or loose stools, come back mildly after a gap, particularly if the gap was longer. This mirrors the pattern seen when starting treatment: the NHS tirzepatide medicines page notes that GI effects are most common at the beginning of treatment or after a dose increase, and a brief interruption can produce something similar.
Appetite returning during a gap is not a sign that the medicine has stopped working. It is a temporary effect of lower drug levels, and it typically settles once regular weekly dosing resumes. That said, if you find appetite returning forcefully between doses even when you have not missed one, that is a useful thing to mention at your next clinical review rather than adjusting anything yourself.
The instruction not to take two doses in the same week is firm. Doubling up does not accelerate results; it substantially increases the likelihood of severe nausea, vomiting and other gastrointestinal effects, and it disrupts the steady state the weekly schedule is designed to maintain.
The same logic applies to storage. If you are unsure whether your pen was left somewhere warm for too long, do not inject it and assume the dose will work, temperature excursions can affect the medicine, and using a compromised pen means you have taken a risk without knowing the outcome. Contact your prescriber or pharmacy if you are in doubt about a pen's condition.
On the question of cost, it is worth knowing that Mounjaro pricing in the UK varies between providers, and a missed dose does not mean a wasted prescription if you follow the four-day rule, you simply adjust the schedule. Wasted medicine is a real consideration, though, which is one reason some patients keep a simple weekly reminder.
A single missed dose handled correctly needs no clinical contact beyond your usual review cycle. There are a few situations where reaching out is the right move, though. If you have missed two or more doses in a row, your prescriber may want to consider whether restarting at a lower dose makes sense, returning at full maintenance dose after a significant gap can make GI side effects noticeably worse.
If you are regularly missing doses for logistical reasons (travel, shift work, supply gaps), that pattern is worth discussing at your next review. Consistent weekly dosing is what the clinical trial data is built on: the SURMOUNT-1 trial, published in the New England Journal of Medicine, studied tirzepatide in adults who completed a structured 72-week programme with weekly injections. Real-world adherence matters.
Our prescribers are available seven days a week for aftercare queries. If you have a specific concern about a missed dose or want to understand how a gap might affect your longer-term treatment journey, a quick message through your account is the fastest route to a clinical answer. You can also browse our FAQs for guidance on common injection questions, or read about the Mounjaro injection process in full if any technique questions come up alongside timing ones.
If you are not yet on treatment and want to understand whether Mounjaro is clinically suitable for you, our free consultation is the right starting point, reviewed the same day by a GPhC-registered prescriber, not a queue or an algorithm.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.